Trade Gilead ^GILD

Is Gilead Sciences (GILD) Among the Best Low Volatility Blue Chip Stocks to Buy Now?

Gilead Sciences Details Tubulis, Ouro, Arcellx Deals as Pipeline Catalyst, 2026 Updates Loom

Is It Time To Reassess Gilead Sciences (GILD) After Its Strong Multi Year Share Price Run

EQT Life Sciences to exit minority stake in Tubulis via sale to Gilead Sciences for up to USD 5.0 billion

Gilead Sciences to Buy Clinical-Stage Biotech Tubulis for Up to $5 Billion - Update | Morningstar

Gilead to buy cancer biotech Tubulis in US$5 billion deal - The Business Times

Gilead to acquire Tubulis GmbH for up to $5 billion

Gilead Sciences (NASDAQ:GILD) Price Target Raised to $123.00 at Royal Bank Of Canada - Stock Observer

Robinhood Asset Management LLC Invests $593,000 in Gilead Sciences, Inc. $GILD - Daily Political

Trueblood Wealth Management LLC Takes Position in Gilead Sciences, Inc. $GILD - Markets Daily

Assessing Gilead Sciences (GILD) Valuation After Its Strong Multi Year Share Price Run

Kelleher Financial Advisors Increases Holdings in Gilead Sciences, Inc. $GILD

Perpetual Ltd Raises Position in Gilead Sciences, Inc. $GILD

Galapagos NV (GLPG) Signs Agreement with Gilead on Ouro Medicines Assets

Gilead Sciences, Inc. (NASDAQ:GILD) Given Consensus Rating of "Moderate Buy" by Analysts

Best Pharmaceutical Stocks To Follow Today - April 3rd - Markets Daily

Gilead Sciences Advances Growth Strategy with Focus on HIV

Gilead Sciences, Inc. $GILD Position Reduced by Aberdeen Group plc

Bristol Myers Squibb, Gilead Sciences to review media accounts

HF Advisory Group LLC Buys 13,212 Shares of Gilead Sciences, Inc. $GILD

Banque Pictet & Cie SA Purchases 142,543 Shares of Gilead Sciences, Inc. $GILD

A Look At Gilead Sciences (GILD) Valuation After Recent Mixed Share Price Performance

Gilead Extends Deadline on Tender Offer to Acquire Arcellx | Morningstar

Gilead Sciences's Q1 2026 Earnings: What to Expect

Gilead Sciences, Inc. $GILD Stock Holdings Raised by Nisa Investment Advisors LLC

Gilead Sciences, Inc. $GILD Shares Acquired by Moody Lynn & Lieberson LLC

Meyer Handelman Co. Has $41.33 Million Holdings in Gilead Sciences, Inc. $GILD

Gilead Sciences, Inc. $GILD Shares Bought by Mn Services Vermogensbeheer B.V.

Gilead Expands Autoimmune Ambitions With Ouro Deal And Galapagos Collaboration

Galapagos and Gilead Enter into Binding Agreement to Collaborate on Advancing First in Class T Cell Engager Program for Autoimmune Diseases

6,329 Shares in Gilead Sciences, Inc. $GILD Acquired by WESPAC Advisors LLC

Quemliclustat and chemotherapy with or without zimberelimab in metastatic pancreatic adenocarcinoma: a randomized phase 1 trial

Gilead Sciences, Inc. $GILD Stake Lifted by USA Financial Formulas

5,845 Shares in Gilead Sciences, Inc. $GILD Bought by Parsons Capital Management Inc. RI - Stock Observer

Synergy Asset Management LLC Has $204,000 Holdings in Gilead Sciences, Inc. $GILD

Exchange Traded Concepts LLC Raises Position in Gilead Sciences, Inc. $GILD

Wedge Capital Management L L P NC Sells 10,133 Shares of Gilead Sciences, Inc. $GILD - Stock Observer

CAR T-Cell Therapy Market to Hit USD 13.78 Billion by 2031, Driven by Rising Global Cancer Prevalence - Insights by Product, Target, Indication, Demographic, Region, and Competitive Landscape

Gilead Sciences FY2026 EPS Increased by Erste Group Bank

NatWest Group plc Has $5.40 Million Stock Holdings in Gilead Sciences, Inc. $GILD

FY2026 EPS Forecast for Gilead Sciences Lifted by Analyst - Stock Observer

Gilead Sciences, Inc. $GILD Shares Purchased by Global X Japan Co. Ltd. - Daily Political

A Look At Gilead Sciences (GILD) Valuation After Recent Share Price Weakness

Gilead to Acquire Ouro Medicines in $2.18B Deal, Expand Inflammation Pipeline

Metastatic Triple-Negative Breast Cancer Market: Strong Growth Potential Across APAC Through 2036, Driven by Innovation and Rising Disease Burden | DelveInsight

Czech National Bank Buys 12,009 Shares of Gilead Sciences, Inc. $GILD

17,800 Shares in Gilead Sciences, Inc. $GILD Acquired by Pensionfund Sabic - Markets Daily

Pensionfund Sabic Takes $2.19 Million Position in Gilead Sciences, Inc. $GILD - Stock Observer

Gilead Eyes $2.2 Billion Autoimmune Push With Ouro Deal

Gilead Expands Into Autoimmune With Ouro Deal And Galapagos Alliance

Rights to antibody drug by China's Keymed change hands in Gilead acquisition of Ouro | South China Morning Post

Gilead pens dual-purpose $2B Ouro M&A deal with Galapagos | BioWorld

Gilead Sciences Acquires Ouro Medicines for Over $2 Billion to Expand Immunology Pipeline, ETPharma

Dow Jones Top Company Headlines at 9 PM ET: Estee Lauder in Talks to Acquire Spain's Puig to Create Global Beauty Giant | Gilead ... | Morningstar

Gilead Sciences to Buy Ouro Medicines, Collaborate With Galapagos on Purchased Assets - Update | Morningstar

Gilead to buy Ouro Medicines for up to $2.2 billion

Gilead Sciences to Buy Ouro Medicines for Up to $2.18 Billion | Morningstar

Gilead to buy biotech firm Ouro Medicines in over $2 billion deal

Galapagos and Gilead in Advanced Discussions to Collaborate on Advancing First in Class T Cell Engager Program for Autoimmune Diseases

Galapagos en Gilead in vergevorderde gesprekken over samenwerking om een first-in-class T-cel-engagerprogramma voor auto-immuunziekten verder te ontwikkelen

-- Acquisition Adds Clinical Stage Bispecific BCMAxCD3 T Cel

Gilead Sciences to Acquire Ouro Medicines to Advance First in Class T Cell Engager Program for Autoimmune Diseases

Demand surges in Nigeria for new HIV prevention injection ahead of rollout | Africanews

Wealth Enhancement Advisory Services LLC Has $77.22 Million Stock Holdings in Gilead Sciences, Inc. $GILD

Nordea Investment Management AB Has $630.06 Million Stake in Gilead Sciences, Inc. $GILD

Henrickson Nauta Wealth Advisors Inc. Purchases 7,074 Shares of Gilead Sciences, Inc. $GILD - Markets Daily

Nordea Investment Management AB Increases Position in Gilead Sciences, Inc. $GILD - Stock Observer

IAM Advisory LLC Takes $1.27 Million Position in Gilead Sciences, Inc. $GILD

BCGM Wealth Management LLC Makes New Investment in Gilead Sciences, Inc. $GILD

Union Bancaire Privee UBP SA Grows Stock Holdings in Gilead Sciences, Inc. $GILD - Daily Political

Therapeutics Stocks Q4 Teardown: Moderna (NASDAQ:MRNA) Vs The Rest

Groupama Asset Managment Grows Stock Holdings in Gilead Sciences, Inc. $GILD

Anderson Hoagland & Co. Purchases New Stake in Gilead Sciences, Inc. $GILD

AIA Group Ltd Increases Stock Position in Gilead Sciences, Inc. $GILD

Gilead Sciences, Inc. $GILD Shares Sold by Wilmington Savings Fund Society FSB - Daily Political

GILD: HIV Franchise And Oncology Expansion Will Shape Bullish Long Term Outlook

Combination Therapies Reshape Oncology: A $748B Market Shifts Standard of Care

Gilead Sciences, Inc. $GILD Shares Bought by Swiss Life Asset Management Ltd

Johanna Mercier Sells 3,000 Shares of Gilead Sciences (NASDAQ:GILD) Stock - Markets Daily

Swiss Life Asset Management Ltd Purchases 31,807 Shares of Gilead Sciences, Inc. $GILD - Stock Observer

Sunbelt Securities Inc. Trims Holdings in Gilead Sciences, Inc. $GILD - Daily Political

A Look At Gilead Sciences (GILD) Valuation As Recent Returns Send Mixed Signals

Danske Bank A S Takes $133.05 Million Position in Gilead Sciences, Inc. $GILD

Captrust Financial Advisors Has $211.80 Million Stock Holdings in Gilead Sciences, Inc. $GILD - Markets Daily

Gilead Sciences, Inc. $GILD Shares Purchased by Achmea Investment Management B.V.

Gilead Sciences, Inc. $GILD Holdings Cut by WBI Investments LLC - Daily Political

Gilead Sciences (NASDAQ:GILD) Insider Johanna Mercier Sells 3,000 Shares

Gilead Sciences (NASDAQ:GILD) CFO Sells $432,690.00 in Stock